Editor’s Note: This is a long contributor article, so I have included links to skip to different sections.
Why is a labeling system needed for cannabis?
The purpose of a labeling system is to communicate the contents of a product to an interested observer. The observer could be a prospective consumer about to make a purchase or a producer or broker who is negotiating industrial scale purchases and sales of product.
In many industries, such as food, labeling conventions have been well-established. The FDA has developed very specific guidelines for foods, showing the now famous “Nutrition Facts” label that displays the three basic biomolecular categories: protein, carbohydrates, and fats. Looking at this label, a person can get a sense of what they are about to ingest. For example butter, olive oil, coconut oil, and avocado are all very high in fats. Wheat, potato, corn, rice, and sugarcane are all almost entirely carbohydrates. Meats and beans have very high protein contents. Most nuts are considered as “superfoods” because they contain an even balance of protein, carbs, and fats.
Another example exists in the pharmaceutical industry, which is also regulated by the FDA. The labels for drugs are very different from the food industry. Whereas food represents a living continuum of countless chemical diversity, drugs are designed to ideally have only one or two active ingredients per pill, with the rest made up of an inactive filler. Pharmaceuticals are rather easy to label because all one needs to do is label the dose of the active compound and the consumer knows all they need to know about a particular formulation of a medicine.
How does the DiscOmic labeling system work?
There are two critical components to the DiscOmic system: statistical analysis using artificial intelligence (A.I.) algorithms and biochemical enzymology. The AI component explores and discovers relationships between terpene groups, and the enzymology component verifies and validates statistical patterns observed in the data gathered from the studies.
- Russo, Ethan B. “Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects.” British journal of pharmacology 163.7 (2011): 1344-1364.
- Russo, Ethan B., and John M. McPartland. “Cannabis is more than simply Δ 9-tetrahydrocannabinol.” Psychopharmacology 165.4 (2003): 431-432.
- What is Cannabidiol? | Project CBD – https://www.projectcbd.org/science/terpenes/terpenes-and-entourage-effect
- CNN | Dr. Sanjay Gupta – https://edition.cnn.com/2014/03/11/health/gupta-marijuana-entourage/
- McPartland, John M., and Ethan B. Russo. “Cannabis and cannabis extracts: greater than the sum of their parts?.” Journal of Cannabis Therapeutics 1.3-4 (2001): 103-132.
- Croteau, Rodney. “Biosynthesis and catabolism of monoterpenoids.” Chemical Reviews 87.5 (1987): 929-954.
Using Science to Identify the Best CBD Products – An Interview with Austin Flohrschutz of TruPotencyNovember 14, 2019
An Illuminating Interview with Andrew Myers of ProGrowTechOctober 21, 2019
Captiva Verde Completes Acquisition of a Full Authority to Import, Market and Distribute All Cannabis Products in MexicoOctober 4, 2019
Business Relationships in the Cannabis IndustryOctober 3, 2019
Do you want to receive the next Grower’s Spotlight as soon as it’s available? Sign up below!
Want to get in touch with Marco? He can be reached via the following methods:
Do you have any questions or comments?
About the Author
Digamma Consulting is a full-service laboratory and consulting firm for cannabis. Savino Sguera and Marco Troiani are leading partners for Digamma and have years of experience under their belts. Their market analyses and scientific insights have been well-received here at Growers Network.